Inhaled aztreonam by O'Sullivan Brian P, Yasothan Uma, Kirkpatrick Peter in Nature reviews. Drug discovery (2010). PubMed

Abstract

In February 2010, aztreonam for inhalation solution (Cayston; Gilead) - an inhalable formulation of the monobactam antibiotic aztreonam and lysine - was approved by the US FDA to improve respiratory symptoms in patients with cystic fibrosis infected with Pseudomonas aeruginosa.

[ hide abstract ]

Discussed In Paper

Related In Paper

Variant Annotations

None.